BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 19656781)

  • 21. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents.
    Shi W; Chen Z; Chen X; Cao L; Liu P; Sun S
    FEMS Yeast Res; 2010 Nov; 10(7):885-93. PubMed ID: 20707818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
    Lamfon H; Porter SR; McCullough M; Pratten J
    J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fungicidal activity of miconazole against Candida spp. biofilms.
    Vandenbosch D; Braeckmans K; Nelis HJ; Coenye T
    J Antimicrob Chemother; 2010 Apr; 65(4):694-700. PubMed ID: 20130024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
    Xu Y; Chen L; Li C
    J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
    J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of fluconazole-resistant sterol 14-demethylase P450 (CYP51) in Candida albicans is a model demonstrating the diversification mechanism of P450.
    Aoyama Y; Kudo M; Asai K; Okonogi K; Horiuchi T; Gotoh O; Yoshida Y
    Arch Biochem Biophys; 2000 Jul; 379(1):170-1. PubMed ID: 10864455
    [No Abstract]   [Full Text] [Related]  

  • 28. Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans obtained from denture wearers.
    Lyon JP; de Resende MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Nov; 102(5):632-8. PubMed ID: 17052640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease in Candida albicans strains with reduced susceptibility to fluconazole following changes in prescribing policies.
    Lopez J; Pernot C; Aho S; Caillot D; Vagner O; Dalle F; Durnet-Archeray MJ; Chavanet P; Bonnin A
    J Hosp Infect; 2001 Jun; 48(2):122-8. PubMed ID: 11428879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
    Ribeiro MA; Paula CR
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):71-5. PubMed ID: 16839736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistant mechanisms of Candida albicans to fluconazole.
    Wang W; Li R; Wang D; Li S; Zhu L; Wang X; Wan Z; Zhai W
    Chin Med J (Engl); 1999 May; 112(5):466-71. PubMed ID: 11593521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans.
    Arai R; Sugita T; Nishikawa A
    Mycoses; 2005 Jan; 48(1):38-41. PubMed ID: 15679664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of Upc2p-Inducible
    Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
    mBio; 2018 May; 9(3):. PubMed ID: 29789366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4.
    Hitchcock CA; Russell NJ; Barrett-Bee KJ
    Crit Rev Microbiol; 1987; 15(1):111-5. PubMed ID: 3319418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-Erythroascorbic acid activates cyanide-resistant respiration in Candida albicans.
    Huh WK; Song YB; Lee YS; Ha CW; Kim ST; Kang SO
    Biochem Biophys Res Commun; 2008 May; 369(2):401-6. PubMed ID: 18282465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
    Bruzual I; Riggle P; Hadley S; Kumamoto CA
    J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
    Kurnatowski P; Makieło L; Horwatt-Bozyczko E
    Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis.
    Sharma M; Manoharlal R; Negi AS; Prasad R
    FEMS Yeast Res; 2010 Aug; 10(5):570-8. PubMed ID: 20528949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Candida albicans resistance and genotyping by randomly amplified polymorphic DNA method].
    Qian J; Zha GZ; Yu P
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):327-30. PubMed ID: 12205990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans.
    Favre B; Didmon M; Ryder NS
    Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2715-25. PubMed ID: 10537193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.